NRX Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
NRX Pharmaceuticals, Inc.
CIK #0001719406
EDGAR Form CIK 2011 - 2025
10-K [0001719406]
10-Q [0001719406]
3 [0001719406]
4 [0001719406]
5 [0001719406]
8-K [0001719406]
D [0001719406]
SC 13D [0001719406]
SC 13G [0001719406]
Form 13D/13G Filer Form 13D/13G Subject Filed
Anson Funds Management LP NRX Pharmaceuticals Inc [2025-05-15]
Javitt Daniel C NRX Pharmaceuticals Inc [2022-09-13]
Javitt Jonathan C NRX Pharmaceuticals Inc [2022-06-03]
Javitt Jonathan C NRX Pharmaceuticals Inc [2021-06-03]
K2 Principal Fund LP Big Rock Partners Acquisition Corp [2020-02-13]
Magnetar Financial LLC Big Rock Partners Acquisition Corp [2020-02-13]
Oxford Asset Management LLP Big Rock Partners Acquisition Corp [2020-02-13]
HGC Investment Management Inc Big Rock Partners Acquisition Corp [2019-02-13]
BRAC Lending Group LLC Big Rock Partners Acquisition Corp [2018-11-26]
Polar Asset Management Partners Inc Big Rock Partners Acquisition Corp [2018-02-13]
View All
Form 3/4/5 Subject 2011 - 2025
NRX Pharmaceuticals, Inc.
Abrams Michael S
Javitt Jonathan C
McBride Dennis
Rehnquist Janet
Narido Richard Clavano
Hurvitz Chaim
Gorovitz Aaron
van Voorhees Seth
Willard Stephen H
View All
Terms | Privacy | Guide
tony@aum13f.com